Worldwide Use of Sodium Glucose Co-transporter 2 Inhibitors in Immunoglobulin A nephropathy: A country and Regional Analysis

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/9797ae4bfe93857910e4b84cc3b845e9.pdf

Abstract Title

First Name *

Chee Kay

Last Name *

Cheung

Co-author 1

Chris Christodoulou cchristodoulou@georgeclinical.com George Clinical Scientific Leadership Surrey

Co-author 2

Ben Talbot btalbot@georgeinstitute.org.au The George Institute for Global Health, University of New South Wales Cardiovascular Division Sydney

Co-author 3

Michelle Wong michellemywong@gmail.com University of British Columbia Division of Nephrology Vancouver

Co-author 4

Maria Ali mali@georgeclinical.com George Clinical Scientific Leadership Kansas

Co-author 5

Inna Kolesnyk ikolesnyk@georgeclinical.com George Clinical Scientific Leadership Kansas

Co-author 6

Nasir Shah Nasir.Shah@health.nsw.gov.au University of New South Wales School of Clinical Medicine Sydney

Co-author 7

Muh Geot Wong Muh.Wong@health.nsw.gov.au University of Sydney Concord Clinical School Sydney

Co-author 8

Roberto Pecoits-Filho Roberto.Pecoits@arborresearch.org Ann Arbor Arbor Research Michigan

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15